Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation

Bibliographic Details
Main Authors:	Omid Kiamanesh, MD, Deirdre O’Neill, MD, Soori Sivakumaran, MD, FRCPC, Shane Kimber, MD, FRCPC
Format:	Article
Language:	English
Published:	Elsevier 2015-07-01
Series:	HeartRhythm Case Reports
Subjects:	Defibrillators implantable Subcutaneous ICD ICD sensing Cardiac arrest Ventricular arrhythmias
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027115000901

Similar Items

T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator
by: Muhammad R. Afzal, MD, et al.
Published: (2017-08-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia
by: Kosuke Aoki, et al.
Published: (2015-12-01)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)

“Carryover phenomenon” in subcutaneous implantable cardioverter‐defibrillator: Residual energy caused early shock to subsequent ventricular tachycardia
by: Yasunobu Yamagishi, et al.
Published: (2022-06-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R-wave amplitude variation: Another challenge in device management
by: Syeda A. Batul, MD, et al.
Published: (2017-01-01)

Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD
by: Mikhael F. El-Chami, MD, et al.
Published: (2016-06-01)

Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)

Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series
by: Viveka Kumar, et al.
Published: (2022-04-01)

The subcutaneous implantable cardioverter defibrillator in daily clinical practice
by: Tardu Özkartal, et al.
Published: (2017-10-01)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
by: Luis A. Pires
Published: (2007-08-01)

Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry
by: Vincenzo Russo, et al.
Published: (2022-05-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes
by: Pier D. Lambiase, MBChB, PhD, FHRS, et al.
Published: (2020-12-01)

Subcutaneous ICD lead position affects defibrillation threshold
by: Hariharan Sugumar, MBBS, BMedSci, et al.
Published: (2018-01-01)

Intra-Abdominal Hemorrhage Triggering Inappropriate Therapy From a Subcutaneous Defibrillator
by: Michael M. Malaty, MBBS, et al.
Published: (2024-02-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Evolution of extravascular implantable cardioverter-defibrillator therapy for ventricular arrhythmias
by: Hans Römers, MSc, et al.
Published: (2023-01-01)

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
by: Paola Berne, MD, et al.
Published: (2017-10-01)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)

Revision of subcutaneous implantable cardioverter defibrillator to intermuscular pocket to prevent inappropriate shocks
by: Jeko M. Madjarov, et al.
Published: (2020-06-01)

Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators
by: Luca Santini, MD, PhD, et al.
Published: (2017-06-01)

Oversensing caused by trapped air in the header of subcutaneous cardioverter‐defibrillator generator
by: Takuya Okada, et al.
Published: (2023-10-01)

Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft
by: Thomas A. Boyle, et al.
Published: (2016-09-01)

Inappropriate shocks in a patient with a subcutaneous implantable cardioverter-defibrillator
by: Sana M. Al-Khatib, MD, MHS, FHRS, et al.
Published: (2016-11-01)

An unusual cause for inappropriate defibrillator shock
by: Debabrata Bera, et al.
Published: (2022-09-01)

Simultaneous leadless pacemaker and subcutaneous implantable cardioverter‐defibrillator implantation—When vascular options have run out
by: Jit Beng Ng, et al.
Published: (2019-02-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
by: Krishnakumar Nair, et al.
Published: (2014-07-01)

Inappropriate defibrillator shock due to EMI despite noise reversion and SecureSense - What is the mechanism?
by: Sanjeev S Mukherjee, et al.
Published: (2022-03-01)

Systematic Review on S-ICD Lead Extraction
by: Riccardo Vio, et al.
Published: (2023-05-01)

Inappropriate defibrillator shock due to oversensing. What is the mechanism?
by: Debabrata Bera, et al.
Published: (2021-01-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
by: Martina Nesti, et al.
Published: (2023-10-01)

A novel cause of inappropriate subcutaneous implantable cardioverter-defibrillator therapies after a generator change
by: Timothy M. Markman, MD, et al.
Published: (2021-08-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)